Latest advanced prostate cancer Stories
SAN FRANCISCO and TOKYO, Sept. 29 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma Inc.
DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Center in Detroit was recently selected to be one of 50 sites in the United States to offer the new U.S.
HORSHAM, Pa., Sept. 1 /PRNewswire/ -- World-renowned golf champion and prostate cancer survivor Arnold Palmer has teamed up with Centocor Ortho Biotech Inc.
PARSIPPANY, N.J., Aug.
THOUSAND OAKS, Calif., June 5 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial which compared the efficacy and safety of denosumab versus ZometaÂ® (zoledronic acid) in 1,901 patients with hormone-refractory prostate cancer and bone metastases.
WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA).
SILVER SPRING, Md., April 29 /PRNewswire-USNewswire/ -- The U.S.
An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer.
MORRISTOWN, N.J., March 11 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced the U.S.
ABBOTT PARK, Ill., March 11 /PRNewswire-FirstCall/ -- The U.S.
- A serpent whose bite was fabled to produce intense thirst.